Abstract: The cause of histiocytic necrotizing lymphadenitis (HNL) has been ascribed to viral infection, but its pathogenesis still remains unknown. Real-time PCR assays are useful not only for their sensitivity of detection but also for the quantitation of viral DNA with a wide linear range. We accordingly used this technique to estimate for each patient the viral load of the following members of the herpesvirus family: Epstein-Barr virus (EBV), cytomegalovirus (CMV), and human herpesvirus (HHV) types 6, 7, and 8. Samples of patients diagnosed as reactive lymphadenopathy (RL) were included for control. Thirty percent (6/20 cases) and 63% (12/19 cases) of the HNL and RL patients were positive for EBV, and the mean of the detectable EBV viral load of the HNL and that of the RL patients were 463 and 355 (copies/mg DNA), respectively. By in situ hybridization, EBV-encoded RNA could be detected in the lymph tissue samples with more than 14.3 copies/mg of EBV DNA. No significant difference was detected between the number of HNL patients with HHV6 DNA (3/20, 15%) or HHV7 DNA (2/20, 10%) and RL controls. CMV and HHV8 were not detected in the DNA from any patient. In this study, we were unable to definitively identify the causative herpesvirus for HNL; however, 1 HNL case had an extremely large copy number of HHV6-DNA and displayed positive immunostaining for the HHV6 early/late antigen in lesional areas of the node, suggesting that HHV6 infection may be associated with some cases of HNL.
H istiocytic necrotizing lymphadenitis (HNL), also known as subacute necrotizing lymphadenitis or Kikuchi-Fujimoto disease, is a self-limited benign disease of unknown etiology.
1-3 HNL is a rare disorder, except among East Asians, but has now become recognized in many regions of the world. The disease is typically identified in young adults in their third decade and usually begins with pyrexia, flu-like symptoms, and localized lymphadenopathy, generally found in the neck region. Laboratory exams often show an increase in erythrocyte sedimentation, neutropenia, and lymphocytosis. In most cases, lymphadenopathy and other clinical manifestations resolve spontaneously in 1 to several months, followed by a complete recovery with an infrequent incidence of recurrence. 3 The diagnosis is made by the histologic examination of a lymph node biopsy or fine-needle aspiration cytology. Pathologic examination of diseased tissue reveals fibrinoid necrosis with apoptotic cells and virtually no infiltration of neutrophils, patchy loss of lymph node structure with many histiocytes as well as relatively distinct areas of residual normal tissue, and no sign of granulomatous reaction. [3] [4] [5] [6] [7] [8] [9] [10] These pathologic features enable us to differentiate HNL from other types of necrotizing lymphadenopathy, such as pyogenic infections and malignant lymphomas, especially those with massive necrosis. [11] [12] [13] Clinical and histologic evidence, including an increase in the number of atypical lymphocytes and reactive histiocytes, has suggested a viral origin for HNL, with the suspected agents including Epstein-Barr virus (EBV), human herpesvirus 6 (HHV6), and cytomegalovirus (CMV). None of these, however, has yet obtained a consensus as the pathogenic origin of HNL. [14] [15] [16] [17] [18] [19] [20] [21] [22] Members of the family herpesviridae have been classified into 3 subfamilies on the basis of their biologic properties, DNA sequence homology, and genome arrangement: alpha herpesviridae, beta herpesviridae, and gamma herpesviridae. 23 We selected 5 viral species to investigate in this study, namely, Epstein-Barr virus (EBV), cytomegalovirus (CMV), and human herpesvirus (HHV) types 6, 7, and 8. These all belong to either the beta-or gammaherpesvirus subfamilies, most of which are ubiquitous in the human population and are known to cause chronic, latent, and recurrent infections.probe using real-time laser scanning in a 96-well plate. This assay requires minimal handling and enables us to quantify viral DNA accurately and reproducibly over a very wide dynamic range. Using this highly sensitive PCR method, a system to quantify CMV, EBV, HHV6, and HHV7 genomes has previously been established to estimate viral load and diagnose or monitor these viral infections. [25] [26] [27] [28] [29] In addition, in this study, we have developed a system to monitor HHV8 infection and have quantified the viral load in lymph nodes from patients with HNL. Latent viruses such as CMV or EBV can sometimes be detected even in specimens from healthy seropositive individuals; hence, quantitative analysis from the specific, infected lymph nodes is essential to investigate viral pathogenicity.
To our knowledge, this is the first report that comprehensively investigated several viruses in HNL lymph-node specimens using real-time quantitative PCR and also the first to detect HHV7 infection in HNL by this method. Furthermore, we corroborated the data from the real-time PCR assay with in situ hybridization (ISH) analysis and immunohistochemistry.
MATERIALS AND METHODS

Patients and Samples
Twenty cases of HNL were collected between January 1997 and October 1999 from the Department of Pathology of Biologic Response, Nagoya University Graduate School of Medicine, Nagoya, Japan. Nineteen biopsy samples from cases of reactive lymphadenopathy (RL) were included as negative controls. RL is defined as a nonspecific lymphadenitis in patients who received a lymph node biopsy because of clinically indicated lymphadenopathy. In these patients, pathologic examination revealed that the lymph nodes were nonneoplastic. We also obtained 4 lymph node specimens from patients without any clinically apparent lymph node enlargement or tumor metastasis, who had received a thyroidectomy due to thyroid cancer. For the PCR assay, DNA was extracted from the tissue samples, which had been fixed in periodate-lysine-paraformaldehyde fixative and frozen, using QIAamp DNA Mini Kit (QIAGEN).
Real-Time Quantitative PCR With a Fluorogenic Probe
The primers and probe settings used for EBV, CMV, HHV6, and HHV7 were as described in previous reports. [25] [26] [27] [28] [29] The PCR probe and primers for HHV8 were selected from ORF26 and are shown below: HHV8 upstream primer:
0 , where <F> = FAM (6-carboxy-fluorescein) and <T> = TAMRA (6-carboxy-tetramethyl-rhodamine). The PCR reaction was performed using a TaqMan PCR Kit (PE Applied Biosystems, Foster City, CA) and a model 7700 Sequence Detector (PE Applied Biosystems) as previously described. A standard graph was constructed using the threshold cycle (CT) values obtained with a serially diluted plasmid (containing the target gene) as a positive control template. The CT values from the clinical samples were plotted on the standard curve, and the copy number was calculated automatically using Sequence Detector v1.6 (PE Applied Biosystems). Samples were defined as negative when the CT value exceeded 50 cycles. The detection limit for each viral DNA sample was approximately 10 copies/mg of DNA.
In Situ Hybridization for the Detection of EBERs (EBERs-ISH) and Immunohistochemistry for HHV6
Both detection assays were performed on formalinfixed, paraffin-embedded sections. The ISH assay was performed by first applying an Epstein-Barr virus probe (Novocastra Laboratories Ltd, Newcastle, UK) that contains a random mixture of FITC-labeled oligonucleotides that hybridize to EBER1 and EBER2 (EBERs). Subsequently, an anti-FITC antibody was added, which was then detected using the Ultratech HRP streptavidinbiotin universal detection system (Immunotech, Marseille, France). Immunohistochemistry was performed with the mouse anti-HHV type 6 early/late antigen monoclonal antibodies (Chemicon International Inc, Temecula, CA). The avidin-biotin-peroxidase complex method was accomplished using the Ultratech HRP streptavidin-biotin universal detection system.
RESULTS
Clinicopathological Findings
The HNL patients in this study were 11 females and 9 males who ranged in age from 15 to 53 years old (median, 24.5) ( Table 1) . Follow-up information was available for 19 patients that indicated a complete resolution of the disease in all patients. The RL cases used as controls were 10 females and 9 males who ranged from 1 to 75 years old (median, 28.0).
All HNL cases displayed features of HNL. Distinguishing features of HNL include a discrete focal pattern of disease infiltration, abundant karyorrhectic debris, and prominent plasmacytoid monocytes and histiocytes with twisted nuclei. In reviewing the available material from each patient, 3 main histologic types emerged: proliferative type (PT), necrotizing type (NT), and xanthomatous type (XT) (Fig. 1 ), which were consistent with previous reports. 30 
Quantitation of Herpesvirus DNA in Lymph Nodes of Patients With HNL
The mean EBV-DNA copy number found in the EBV-positive HNL patients (Table 2 ) (6/20, 30.0%) was 463 copies/mg of DNA and 355 in RL control patients (12/19, 63.2%). The amount of EBV-DNA ranged from 8.48 to 2,610 copies/mg of DNA.
HHV6-DNA was detected in 3/20 HNL cases (15.0%) and 1/19 RL (5.3%). The mean DNA copy number of 2 of the HHV6-positive HNL samples (a9 and a17) was around 31.4 copies/mg of DNA, a similar value to the DNA copy number present in the HHV6-positive RL sample, 25.0 copies/mg of DNA. The copy number observed for the remaining HNL patient (a20) was extremely large at 7.68 Â 10 5 copies/mg of DNA. The mean HHV7-DNA copy number was 260 copies/mg of DNA in patients with HNL (2/20, 10.0%) and 225 in RL control patients (4/19, 21.1%), which did not indicate a significant difference. Neither CMV nor HHV8 were detected in any of the tissue samples by the real-time PCR assay.
Statistical Analysis
Because of the low frequency of positive PCR results for CMV, HHV6, HHV7, and HHV8, statistical analysis could not be performed. The frequency of positive PCR tests for EBV DNA in the 2 groups was compared using Fisher exact test and displayed almost no significant difference (P = 0.056, Fisher exact test).
EBERs In Situ Hybridization and Immunohistochemistry
Using in situ hybridization, EBERs (Table 2 , Fig. 2) were detected in tissue samples with more than 14.3 copies/mg of DNA, and many positive cells were seen in samples with more than 1,000 copies/mg of DNA. We did not obtain positive results for EBERs-ISH in samples that contained less than 14.3 copies/mg of EBV DNA ( Table 2) . Immunostaining (Fig. 3) for the HHV6 early/late antigen was also performed. In the patient (a20) exhibiting a very large HHV6-DNA copy number, the early antigen was visible in lesional areas of the node. The others samples were negative for HHV6-antigen staining.
DISCUSSION
Several features of HNL suggest that it is caused by an infectious agent. Serologic results have shown an elevation in serum antibody titers to viruses, bacteria, and parasites, such as EBV, CMV, HHV6, [14] [15] [16] human T-cell leukemia lymphoma virus, 21, 22 Yersinia enterocolitica, 31 Toxoplasma gondii, 32 and Brucella melitanis. 33 Previous efforts to determine the causative infectious agent have used PCR, ISH, immunohistochemistry, and electron microscopy, among other techniques, to look for the presence of herpes simplex types 1 and 2, varicella zoster virus, human parvovirus B19, Kaposi sarcoma-associated herpesvirus, known as HHV8, in addition to agents identified by serological examination. [14] [15] [16] [17] [18] [34] [35] [36] [37] The evidence obtained thus far has not convincingly identified the causative agent.
The real-time quantitative PCR assay we applied in this study could detect and quantify from 10 to over 10 7 copies of viral DNA with a wide linear range. This realtime PCR assay was as sufficiently sensitive and specific as is ISH for EBV. A recently published study 38 compared EBERs-ISH results with quantitative measures of EBV-DNA copy numbers. We also have clearly demonstrated that EBERs-ISH frequently positive samples all display relatively high EBV copy numbers (higher than 1,000 copies/mg), due to the higher sensitivity inherent in the real-time quantitative PCR assay, which confirms the reliability of our data. Therefore, we suggest that the quantitation of viral DNA in lymph node specimens is a good method for determining active viral infections. However, using this quantitative technique, we could not conclusively identify a herpesvirus candidate for HNL, which would have to be present in almost all HNL cases but in far fewer RL controls.
Although statistical analysis demonstrated a minimal difference, EBV-DNA was more frequently detected in RL patients (63%) than in HNL patients (30%). This may be due to in part to the difference in ages between the 2 groups (mean 26.4 vs 34.5 years old and median 24.5 vs 28.0 years old for HNL vs RL, respectively). However, considering that 45% and 98% of the Japanese population is latently infected with EBV by the ages of 3 and 40, 39 respectively, it is unlikely that the slight increase in the age of the RL patients, and hence the increase in the percentage with latent infections, would make a large difference in this instance. It is possible that in older patients the immunologic response against EBV-infected cells is weaker, and the number of latently infected cells is larger, causing the DNA level to be more frequently above the detection threshold of the method. This may also explain why the mean EB viral load found in the RL group was significantly higher than that in the HNL group. Another possibility is simply that HNL is relatively rarely associated with EBV. Because even healthy individuals often have latent herpesvirus infections such as EBV in their blood, 39 ,40 the presence of viral genomes does not always indicate an active viral infection or virus-related diseases, and a significant virus load must be defined; 10 2.5 copies/mg of DNA in the serum has been reported as a suitable cutoff level for distinguishing EBV-related lymphoproliferative disorder or chronic active EBV infection from latent EBV infections or asymptomatic reactivation of the virus. In this study, we could not define an appropriate cutoff level for the lymph node because not enough clinical information to confirm disease activity was obtained.
The mean EBV-DNA copy number was not very different between HNL and RL cases (463 vs. 355 copies/ mg DNA). In the 3 cases with a high copy number of more than approximately 1,000 copies/mg of DNA (HNL, 1; RL, 2 cases), EBERs-ISH was also frequently positive. In these cases, EBV may have some role in pathogenesis. The rate of the appearance of cases with a high viral copy number was 17% (1/6) among EBV-positive HNL patients, which was identical to the percentage observed for EBV-positive RL patients (17%; 2/12). Taking all the HNL cases into consideration, the rate was 5% (1/20), which was smaller than that observed for the RL cases (11%; 2/19). Therefore, in a small percentage of RL cases, EBV may be the direct causative agent. We also examined lymph node material with no clinically apparent lymphadenopathy. EBV-DNA was detected in only 1 of 4 of these cases (25%), and the EBV-DNA copy number was low (2.0 copies/mg DNA; data not shown).
CMV-DNA was not detected in any sample using the real-time PCR assay. HHV8 was not also detected. Huh et al 37 recently reported the presence of HHV8-DNA in 6 (23%) of 26 HNL cases by PCR. We used the primers amplifying the same region as the previous study but did not obtain the same results in our samples using quantitative PCR; however, the results obtained by conventional PCR in a more recently published study by George et al 18 were similar to what we observed, and we conclude that HNL is infrequently associated with HHV-8 infection.
HHV6-DNA and HHV7-DNA were detected in just a few samples. One HNL case (a20) displayed a huge copy number for HHV6. This case also exhibited active HHV6 infection using immunohistochemistry, suggesting that HHV6 infection can be associated with some cases of HNL.
Apart from viral infection, a second suggested cause of HNL is an autoimmune response. Some cases of lupus lymphadenitis, also called necrotizing lymphadenitis of systemic lupus erythematosus (SLE), are quite difficult to distinguish from HNL by pathologic features, 41 and cases of subsequently developed SLE in HNL patients have often been reported. It has been proposed that HNL is a self-limited SLE-like autoimmune condition induced by virus-infected transformed lymphocytes. 8, 42 Alternatively, the cause of HNL may be heterogenous. In other words, HNL could be the result of local hyperimmune stimulation after viral, bacterial, or parasitic infection. In this situation, the reactivity of the host could also be a concern for the development of HNL. There has been a study of HLA class II genes that shows significantly higher frequencies of specific alleles in HNL patients when compared with normal controls. 43 It is known that the frequency of HNL is extremely low or absent in persons of Caucasian and African descent but relatively high in those of Asian descent. HNL could be a heterogeneous disorder caused by various pathogens, forming a spectrum of hyperimmune reaction.
In conclusion, we could not detect the prevailing causative agent of HNL using the real-time quantitative PCR assay, except in 1 case of HNL with an active HHV6 infection. This leads us to infer that most cases of HNL may not have a viral cause, with the exception of rare cases caused by HHV6 infection.
